Bio Protocol vs Chainflip — how do they compare? Bio Protocol trades at Rp441.61 (market cap Rp1,01T, Rp168,09M 24h volume), while Chainflip trades at Rp5,087 (market cap --, Rp1,85M 24h volume). The key difference: Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Chainflip's keeps growing, and Bio Protocol is more actively traded (Rp168,09M versus Rp1,85M). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Chainflip for 18 Days on average.
| BIO | FLIP | |
|---|---|---|
Market Cap | Rp1,01T | -- |
Volume (24h) | Rp168,09M | Rp1,85M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | -- |
Typical Hold Time | 18 Days | 18 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Chainflip is transforming the decentralized exchange landscape by enabling seamless, low-slippage swaps between major blockchains. Unlike traditional methods, Chainflip removes the need for wrapped tokens or specialized wallets, making cross-chain transactions more accessible and user-friendly. At its core, Chainflip utilizes a Just-In-Time (JIT) Automated Market Maker (AMM) to facilitate efficient and secure trades.
Read more on FLIP →